Skip to main content

alglucosidase alfa

Generic: alglucosidase alfa·Brand: Lumizyme

alglucosidase alfa: 2 clinical trials tracked.

alglucosidase alfa evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about alglucosidase alfa, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 2 study sponsors

Related indications

No linked indication is available.

Clinical Trials (2)

A Phase 3 Double-blind Randomized Study to Assess the Efficacy and Safety of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease Compared With Alglucosidase Alfa/Placebo

NCT03729362·Phase 3·FOLD
Completed

Primary endpoint: Change From Baseline to Week 52 in 6 Minute Walk Distance (6MWD)

InterventionalRandomizeddouble125 enrolledStarted 2018-12Completion 2021-0150 sites · Argentina, Australia, Austria, Belgium…Amicus Therapeutics

An Open-label Ascending Dose Cohort Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of Avalglucosidase Alfa (NeoGAA, GZ402666) in Patients With Infantile-onset Pompe Disease Treated With Alglucosidase Alfa Who Demonstrate Clinical Decline or Sub-optimal Clinical Response

NCT03019406·Phase 2·SNY
Active, not recruiting

Primary endpoint: PAP: Number of Participants With Treatment-emergent Adverse Events (TEAEs), Serious Treatment-emergent Adverse Events, and Adverse Event of Special Interest (AESI)

InterventionalRandomizedopen22 targetStarted 2017-10Completion 2027-0812 sites · France, Japan, Taiwan, United Kingdom…Genzyme, a Sanofi Company